Skip to main content
Clinical Trials/NCT03076307
NCT03076307
Completed
Not Applicable

Correlation of Procedural Motor Skills Impairment and 123I-FP-CIT SPECT Uptake in Patients With Early Parkinson's Disease: a Case-control Study

University Hospital, Geneva1 site in 1 country9 target enrollmentOctober 18, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
University Hospital, Geneva
Enrollment
9
Locations
1
Primary Endpoint
Procedural motor performance (error and time) in PD group
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Patients with Parkinson's disease (PD) are known to be affected by subtle cognitive impairment early in the disease course, mostly in the executive field. Procedural motor skills, mainly controlled by the basal ganglia associative loop (in particular dorsal caudate nucleus) (Rodriguez-Oroz et al., 2009), have also been studied in patients with PD (Schnider et al., 1995; Muslimovic et al., 2007; Terpening et al., 2013). However, the correlation of dopaminergic 123I-FP-CIT SPECT imaging and cognitive impairment has not been assessed. One reason is the absence of reference values for striatal uptake until recently. Last year, the investigators established local uptake reference values for DAT imaging based on a large cohort of subjects with non-degenerative conditions (Nicastro et al., 2016) and can therefore use these values to precisely assess uptake loss in patients with PD.

With the present study, the investigators expect to enroll patients with early PD for whom a 123I-FP-CIT SPECT has been previously performed in the center. Subjects will perform a specific motor task based on mirror-drawing of star-shaped figures. This will be done by inverting the direction of horizontal/vertical computer mouse movements on the screen. Speed and error rates will be assessed for patients as well as healthy control subjects. Correlation with striatal SPECT uptake, especially caudate nucleus uptake, will be analyzed for PD patients. In addition, resting-state EEG will be performed for all subjects. General medication and dopaminergic drugs in particular, whenever used, will not be discontinued. For all subjects enrolled in the study, cognitive and neurological examination will be performed.

Registry
clinicaltrials.gov
Start Date
October 18, 2016
End Date
July 19, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nicolas Nicastro

Dr. Med. Nicolas NICASTRO

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Procedural motor performance (error and time) in PD group

Time Frame: 2 days

Evaluation of error rate and speed for completion of mirror-drawing of star-shaped figures

Secondary Outcomes

  • Resting state EEG connectivity in PD and control groups(2 days)
  • Difference >20% in error rate and speed improvement in control and PD groups(2 days)

Study Sites (1)

Loading locations...

Similar Trials